Kura Oncology (KURA) PT Raised to $40 at Brookline Capital Markets
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Price: $12.89 +1.90%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 17
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 17
Join SI Premium – FREE
Brookline Capital Markets analyst Leah Rush Cann raised the price target on Kura Oncology (NASDAQ: KURA) to $40.00 (from $35.00) while maintaining a Buy rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Ser Educacional SA (SEER3:BZ) PT Raised to R$23 at JPMorgan
- Robinhood Markets (HOOD) PT Raised to $145 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
